Impact of meningococcal C conjugate vaccine use in Australia

This publication has 10 references indexed in Scilit:

• Australia's century of meningococcal disease: development and the changing ecology of an accidental pathogen
  The Medical Journal of Australia, 2007
• Risk and protective factors for meningococcal disease in adolescents: matched cohort study
  BMJ, 2006
• PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS
  The Pediatric Infectious Disease Journal, 2006
• Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
  The Lancet, 2002
• Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales
  BMJ, 2002
• Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
  Vaccine, 2001
• Should programmes for community-level meningococcal vaccination be considered in Australia? An economic evaluation
  International Journal of Epidemiology, 2001
• Antimeningococcal herd immunity in the Czech Republic – influence of an emerging clone, Neisseria meningitidis ET-15/37
  Epidemiology and Infection, 1999
• Complications and Sequelae of Meningococcal Disease in Quebec, Canada, 1990–1994
  Clinical Infectious Diseases, 1998
• SHIFT IN THE AGE-DISTRIBUTION OF MENINGOCOCCAL DISEASE AS PREDICTOR OF AN EPIDEMIC?
  The Lancet, 1982